Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Journal of Natural Medicines
Published in: Journal of Natural Medicines 1/2016

01-01-2016 | Original Paper

Antiviral effects of Yinhuapinggan granule against influenza virus infection in the ICR mice model

Authors: Xue-qian Peng, Hui-fen Zhou, Yu-yan Zhang, Jie-hong Yang, Hai-tong Wan, Yu He

Published in: Journal of Natural Medicines | Issue 1/2016

Login to get access

Abstract

Yinhuapinggan granule (YHPG), a Chinese medicine granule based on Ma-Huang-Tang (Ephedra Decoction) and the clinical experience of Professor Wan Haitong, is used in traditional Chinese medicine (TCM) for the treatment of colds, influenza, fever, inflammation and cough. This study investigated the antiviral effects of YHPG on the production of inflammatory cytokines in influenza virus (IFV)-infected mice and evaluated the effect of YHPG on the expression of NF-κB p65 and the level of key signaling molecules in the TLR4 signaling pathway. ICR mice were orally administrated YHPG at doses of 7.5, 15 and 30 g kg−1 day−1 for 2 or 6 days after IFV infection. On days 3 and 7 after infection, YHPG (15 g/kg and 30 g/kg) significantly increased levels of interleukin (IL)-2 and interferon gamma and decreased levels of IL-4, IL-5 and tumor necrosis factor (TNF) in serum compared with the IFV control group. Furthermore, the expression of TLR4, MyD88, TRAF6 and NF-κB p65 at the mRNA and protein level was significantly lower in the YHPG (15 and 30 g/kg) treatment groups than in the IFV control group. These results suggest that YHPG has antiviral effects in IFV-infected mice, which is associated with the inhibition of the TLR4−MyD88−TRAF6 signaling pathway and the expression of NF-κB p65.
Literature
1.
Bai GR, Chittaganpitch M, Kanai Y, Li YG, Auwanit W, Ikuta K, Sawanpanyalert P (2009) Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand. Biochem Biophys Res Commun 390:897–901CrossRefPubMed
2.
Kunisaki KM, Janoff EN (2009) Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 9:493–504PubMedCentralCrossRefPubMed
3.
4.
De Clercq E (2006) Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 5:1015–1025CrossRefPubMed
5.
Feng E, Ye D, Li J, Zhang D, Wang J, Zhao F, Hilgenfeld R, Zheng M, Jiang H, Liu H (2012) Recent advances in neuraminidase inhibitor development as anti-influenza drugs. ChemMedChem 7:1527–1536CrossRefPubMed
6.
Michiels B, Van Puyenbroeck K, Verhoeven V, Vermeire E, Coenen S (2013) The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews. PLoS One 8:e60348PubMedCentralCrossRefPubMed
7.
Downes JE, Marshall-Clarke S (2010) Innate immune stimuli modulate bone marrow-derived dendritic cell production in vitro by toll-like receptor-dependent and -independent mechanisms. Immunology 131:513–524PubMedCentralCrossRefPubMed
8.
Marchant D, Singhera GK, Utokaparch S, Hackett TL, Boyd JH, Luo Z, Si X, Dorscheid DR, McManus BM, Hegele RG (2010) Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism. J Virol 84:11359–11373PubMedCentralCrossRefPubMed
9.
10.
11.
Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H et al (2008) Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133:235–249CrossRefPubMed
12.
Nhu QM, Shirey K, Teijaro JR, Farber DL, Netzel-Arnett S, Antalis TM, Fasano A, Vogel SN (2010) Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal Immunol 3:29–39PubMedCentralCrossRefPubMed
13.
Wu XN, Yu CH, Cai W, Hua J, Li SQ, Wang W (2011) Protective effect of a polyphenolic rich extract from Magnolia officinalis bark on influenza virus-induced pneumonia in mice. J Ethnopharmacol 134:191–194CrossRefPubMed
14.
Li L, Yu CH, Ying HZ, Yu JM (2013) Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model. J Ethnopharmacol 147:238–244CrossRefPubMed
15.
Nagai T, Kataoka E, Aoki Y, Hokari R, Kiyohara H (2014) Alleviative effects of a kampo (a Japanese herbal) medicine “Maoto (Ma-Huang-Tang)” on the Early phase of influenza virus infection and its possible mode of action. Evid Based Complement Alternat Med 2014:187036PubMedCentralPubMed
16.
Hsieh CF, Lo CW, Liu CH, Lin S, Yen HR, Lin TY, Horng JT (2012) Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus. J Ethnopharmacol 143:57–67CrossRefPubMed
17.
Zhang BG, Liu QF (2007) Modern pharmacodynamic research and clinical application of Ephedra decoction. Chin Tradit Pat Med 29:415–422
18.
Yang X, Peng WB, Yue XQ (2009) Syndrome differentiation and treatment of Taiyang disease in Shanghan Lun. Zhong Xi Yi Jie He Xue Bao 7:171–174CrossRefPubMed
19.
Mantani N, Andoh T, Kawamata H, Terasawa K, Ochiai H (1999) Inhibitory effect of Ephedrae herba, an oriental traditional medicine, on the growth of influenza A/PR/8 virus in MDCK cells. Antivir Res 44:193–200CrossRefPubMed
20.
Chen KT, Zhou WL, Liu JW, Zu M, He ZN, Du GH, Chen WW, Liu AL (2012) Active neuraminidase constituents of Polygonum cuspidatum against influenza A(H1N1) influenza virus. Zhongguo Zhong Yao Za Zhi 37:3068–3073PubMed
21.
Kubo T, Nishimura H (2007) Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children. Phytomedicine 14:96–101CrossRefPubMed
22.
Kuo KK, Chang JS, Wang KC, Chiang LC (2009) Water extract of Glycyrrhiza uralensis inhibited enterovirus 71 in a human foreskin fibroblast cell line. Am J Chin Med 37:383–394CrossRefPubMed
23.
Wolkerstorfer A, Kurz H, Bachhofner N, Szolar OH (2009) Glycyrrhizin inhibits influenza A virus uptake into the cell. Antivir Res 83:171–178CrossRefPubMed
24.
Lin CJ, Lin HJ, Chen TH, Hsu YA, Liu CS, Hwang GY, Wan L (2015) Polygonum cuspidatum and its active components inhibit replication of the influenza virus through toll-like receptor 9-induced interferon beta expression. PLoS One 10:e0117602PubMedCentralCrossRefPubMed
25.
Michaelis M, Geiler J, Naczk P, Sithisarn P, Leutz A, Doerr HW, Cinatl J Jr (2011) Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression. PLoS One 6:e19705PubMedCentralCrossRefPubMed
26.
Song W, Si L, Ji S, Wang H, Fang XM, Yu LY, Li RY, Liang LN, Zhou D, Ye M (2014) Uralsaponins M-Y, antiviral triterpenoid saponins from the roots of Glycyrrhiza uralensis. J Nat Prod 77:1632–1643CrossRefPubMed
27.
He Y, Yu DJ, Zhang YY, Yang JH, Zhou HF, Wan HT (2014) Anti-tussive effect experiment of Yinhua Pinggan granule. Chin Arch Tradit Chin Med 32:2060–2061
28.
Wan HT, Yu DJ, Lei Y, Bai HB, Yang JH, Bie XD (2002) Anti-inflammatory and analgesic effects experiment of Jin-Ping-Gan granule. Pharmacol Clin Chin Mater Med 18:39–40
29.
Peng HQ, Xu ZM, Wan HT, Yu DJ (2005) Inhibitory effect of Jin-Ping-Gan granule on influenza virus. Zhejiang J Tradit Chin Med 12:87–88
30.
Peng XQ, He Y, Zhou HF, Zhang YY, Chen JK, Lu YY, Wan HT (2015) Effects of Yinghuapinggan granule against influenza A/H1N1 virus in vivo. Zhongguo Zhong yao za zhi (to appear)
31.
Harun A, Vidyadaran S, Lim SM, Cole AL, Ramasamy K (2015) Malaysian endophytic fungal extracts-induced anti-inflammation in Lipopolysaccharide-activated BV-2 microglia is associated with attenuation of NO production and IL-6 and TNF-alpha expression. BMC Complement Altern Med 15:166PubMedCentralCrossRefPubMed
32.
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408CrossRefPubMed
33.
Rajasekaran D, Palombo EA, Chia Yeo T, Lim Siok Ley D, Lee TuC, Malherbe F, Grollo L (2013) Identification of traditional medicinal plant extracts with novel anti-influenza activity. PLoS One 8:e79293PubMedCentralCrossRefPubMed
34.
Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG (2001) Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 64:262–268CrossRefPubMed
35.
Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE (1998) Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101:643–649PubMedCentralCrossRefPubMed
36.
37.
Yu CH, Yan YL, Wu XN, Zhang B, Wang W, Wu QF (2010) Anti-influenza virus effects of the aqueous extract from Mosla scabra. J Ethnopharmacol 127:280–285CrossRefPubMed
38.
Yeo JM, Lee HJ, Kim JW, Lee JB, Park SY, Choi IS, Song CS (2014) Lactobacillus fermentum CJL-112 protects mice against influenza virus infection by activating T-helper 1 and eliciting a protective immune response. Int Immunopharmacol 18:50–54CrossRefPubMed
39.
Kawahara T, Takahashi T, Oishi K, Tanaka H, Masuda M, Takahashi S, Takano M, Kawakami T, Fukushima K, Kanazawa H, Suzuki T (2015) Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model. Microbiol Immunol 59:1–12CrossRefPubMed
40.
Wiley JA, Cerwenka A, Harkema JR, Dutton RW, Harmsen AG (2001) Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am J Pathol 158:119–130PubMedCentralCrossRefPubMed
41.
Weiss ID, Wald O, Wald H, Beider K, Abraham M, Galun E, Nagler A, Peled A (2010) IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner. J Interf Cytokine Res 30:439–449CrossRef
42.
Hussell T, Pennycook A, Openshaw PJ (2001) Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur J Immunol 31:2566–2573CrossRefPubMed
43.
La Gruta NL, Kedzierska K, Stambas J, Doherty PC (2007) A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85:85–92CrossRefPubMed
44.
Abdul-Careem MF, Firoz Mian M, Gillgrass AE, Chenoweth MJ, Barra NG, Chan T, Al-Garawi AA, Chew MV, Yue G, van Roojen N et al (2011) FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice. Antivir Res 92:346–355CrossRefPubMed
45.
Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K, Akira S (2003) TRAM is specifically involved in the toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4:1144–1150CrossRefPubMed
46.
Bradley JR, Pober JS (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20:6482–6491CrossRefPubMed
47.
48.
Lawrence T, Fong C (2010) The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Biol 42:519–523CrossRefPubMed
49.
Wang GF, Shi LP, Ren YD, Liu QF, Liu HF, Zhang RJ, Li Z, Zhu FH, He PL, Tang W et al (2009) Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro. Antivir Res 83:186–190CrossRefPubMed
50.
Hu KJ, Wang YH, Wang D (2010) The inhibited effect of chlorogenic acid from the honeysuckle on virus in vitro. Inf Tradit Chin Med 27:27–28
51.
Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F (1997) Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob Agents Chemother 41:551–556PubMedCentralPubMed
Metadata
Title
Antiviral effects of Yinhuapinggan granule against influenza virus infection in the ICR mice model
Authors
Xue-qian Peng
Hui-fen Zhou
Yu-yan Zhang
Jie-hong Yang
Hai-tong Wan
Yu He
Publication date
01-01-2016
Publisher
Springer Japan
Published in
Journal of Natural Medicines / Issue 1/2016
Print ISSN: 1340-3443
Electronic ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-015-0939-z

Other articles of this Issue 1/2016

Journal of Natural Medicines 1/2016 Go to the issue

Original Paper

Effects of ethyl acetate extract of Kaempferia parviflora on brown adipose tissue

Original Paper

Phytochemical analysis and effects of Pteris vittata extract on visual processes

Original Paper

Purple potato (Solanum tuberosum L.) anthocyanins attenuate alcohol-induced hepatic injury by enhancing antioxidant defense

Rapid Communication

In vitro antituberculosis activity of diterpenoids from the Vietnamese medicinal plant Croton tonkinensis

Original Paper

LC-MS-based quantification method for Achyranthes root saponins

Original Paper

Evodiamine suppresses capsaicin-induced thermal hyperalgesia through activation and subsequent desensitization of the transient receptor potential V1 channels